MD Anderson and SOPHiA GENETICS announce strategic collaboration to accelerate AI-driven precision oncology
The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS’ AI-powered analytics with MD Anderson’s clinical and scientific expertise to accelerate data-driven cancer care through new tools that can accurately analyze, interpret and translate diagnostic results into clinical practice.
As part of the collaboration, MD Anderson and SOPHiA GENETICS are...
Leading cancer research centers reinforce importance of safe and effective HPV vaccination to prevent cancer
62 NCI-designated cancer centers, leading national organizations and the University of Puerto Rico Comprehensive Cancer Center jointly endorse...
MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies
Agreement focuses on rimiducid, an agent used to activate certain safety switch technologies in cell therapies
Phoenix receives a supply of...
MD Anderson and TOPPAN Holdings announce strategic alliance to co-develop organoid technology for evaluating cancer treatments
3D cell culture technology may allow researchers to rapidly test a variety of treatments directly on patient biopsies
Teams will evaluate technology as clinical tool for personalized cancer therapy
Collaboration will aim to obtain CAP/CLIA certification of organoid-based assay, followed by clinical studies in multiple indications
The University of Texas MD Anderson Cancer Center and TOPPAN Holdings today announced a strategic alliance...
UT MD Anderson and Texas Children’s Hospital announce $150 million gift from Kinder Foundation to launch Kinder Children’s Cancer Center
The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital today announced a $150 million gift from Kinder Foundation...
MD Anderson and UT Austin launch joint initiative to advance breakthroughs in cancer research
The University of Texas MD Anderson Cancer Center and The University of Texas at Austin have launched a joint initiative, the Collaborative...
UT MD Anderson and Texas Children’s Hospital Announce Joint Venture to End Childhood Cancer
The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital have announced a transformational collaboration dedicated...
MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assay
The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to accelerate the...
MD Anderson’s Lauren Averett Byers receives TAMEST O’Donnell Award for seminal contributions to lung cancer research
Lauren Averett Byers, M.D., professor of Thoracic/Head & Neck Medical Oncology at The University of Texas MD Anderson Cancer Center...
MD Anderson and AmMax Bio announce agreements to advance development of AMB-066 in colorectal cancer patients with minimal residual disease
The University of Texas MD Anderson Cancer Center and AmMax Bio, Inc. today announced a worldwide exclusive license agreement and clinical...